1. Home
  2. FICO vs RVPH Comparison

FICO vs RVPH Comparison

Compare FICO & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fair Isaac Corproation

FICO

Fair Isaac Corproation

HOLD

Current Price

$1,736.71

Market Cap

41.2B

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.28

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FICO
RVPH
Founded
1956
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.2B
71.0M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
FICO
RVPH
Price
$1,736.71
$0.28
Analyst Decision
Buy
Strong Buy
Analyst Count
12
6
Target Price
$1,999.83
$3.33
AVG Volume (30 Days)
181.6K
7.9M
Earning Date
02-03-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
29.78
N/A
EPS
26.54
N/A
Revenue
$1,990,869,000.00
N/A
Revenue This Year
$24.77
N/A
Revenue Next Year
$17.55
N/A
P/E Ratio
$65.22
N/A
Revenue Growth
15.91
N/A
52 Week Low
$1,300.00
$0.25
52 Week High
$2,217.60
$2.17

Technical Indicators

Market Signals
Indicator
FICO
RVPH
Relative Strength Index (RSI) 45.99 26.65
Support Level $1,726.39 $0.48
Resistance Level $1,767.90 $0.63
Average True Range (ATR) 47.54 0.07
MACD -11.39 -0.04
Stochastic Oscillator 18.19 6.44

Price Performance

Historical Comparison
FICO
RVPH

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: